Insight

December 12, 2022

 Features 
Excellence in Kidney Care and Research: Meet the Winners of the ISN 2023 Awards
Join us in congratulating the ISN 2023 Award winners and get to know their illustrious achievements.
Her Royal Highness Princess Maha Chakri Sirindhorn of the Kingdom of Thailand to Open the World Congress of Nephrology 2023
Find out more about our esteemed WCN'23 royal guest.
Reflections on a Year as Young Nephrologists Committee Chair
Marina Wainstein praises hardworking young nephrologists and reviews a year of activities organized by the Young Nephrologists Committee.
 
 ISN News 
 Membership 
Trainees, Join the ISN for Free or Renew Your Membership
for $15
 EVENTS 
Secure Your Spot at WCN'23 in Bangkok, Thailand - Act Now for the Early Bird Offer!
 Grants 
New 2022 Mentorship Pairings in the ISN Mentorship Program - Online Workshop
for 2021 Pairs
Generous Donation From Renowned Nephrologist's Family Supports ISN Interventional Nephrology Scholar in Peru
 RESEARCH 
Join Us in Congratulating Four New
ISN-Named Fellows  
Access ISN-ACT Webinar on Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors
Explore the ISN Global Trials Focus Selection for November Featuring ‘Trial of the Month’ on Renin-angiotensin System Inhibition in Advanced Chronic Kidney Disease
 Advocacy 
The ISN Joins the European Roundtable Discussion on Tackling Inequities in Kidney Care
 Education/Academy 
Join Us at 6 p.m. on December 16 for the ISN Twitter Space on “Healthy Kidneys for All”
Join Us at 1 p.m. on December 14 for the Encore Presentation of Newly Released EMPA-KIDNEY Trial Data - Download the Visual Abstract
“Approach to Diabetic Kidney Disease” - Parts 1 and 2: Watch and Share Two New Modules in the Open-access Curriculum: Online Kidney Education for Primary Care Physicians
Thank You to ISN Academy Sponsors Who Helped Us Publish More Than 150 Hours of New Material in 2022
UPCOMING WEBINARS
Wednesday, December 14  I  1 p.m. CET
ISN Webinar:
Encore Presentation of EMPA-KIDNEY Trial Data
This webinar is supported by an unrestricted educational grant from
Thursday, December 15  I  2 p.m. CET
ISN Middle East Regional Board Webinar:
Hypertension in the Middle East Region
 
RECORDED WEBINARS
Join or Renew Your Membership here to Access These Webinars
Grand Rounds in Pediatric Nephrology - an ISN-IPNA Sister Centers Initiative:
The Spectrum of Alport Syndrome: Who and How to Investigate?
ISN-ISE Webinar
Endocrine and Metabolic Complications After a Kidney Transplant - Part 2
ISN-ACT Webinar:
Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors (HIF-PHIs)   
This webinar is supported by Astellas.
 ISN JOURNALS 
COVID-19
Access the Latest ISN Journal Articles on Covid-19
KIDNEY INTERNATIONAL EDITORIAL SELECTIONS
Urine: From Waste to Fertilizer
The authors present the case for recycling urine to recover nutrients for use as fertilizers. This practice would positively impact the environment by decreasing man-made nitrogen compounds and water usage.
The results suggest that PM2.5 is an independent risk factor for kidney failure in patients with IgAN.
Implementation Strategies for High-impact Nephrology Trials
The authors discuss the apparent lack of implementation – integrating new practices within a setting, and de-implementation – removing low-value, wasteful or harmful treatments from practice, following kidney trials.
To address this deficit, they examine two frameworks that present promising avenues of inquiry for kidney researchers and urge increased evidence uptake after trial publication to benefit the global kidney care community.
KIDNEY INTERNATIONAL REPORTS EDITORIAL SELECTION
Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate-Lowering Therapy Guidelines for People With Chronic Kidney Disease
The Caring for Australians and New Zealanders with Kidney Impairment (CARI) is an evidence-based guideline on urate-lowering therapy in patients with chronic kidney disease (CKD) rapidly produced in response to new clinical trial publications on the topic by the Australian Kidney Trials Network.
The result is a strong recommendation against using urate-lowering therapies in those with CKD (not receiving dialysis) and asymptomatic hyperuricemia.